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mood or affective states: 1) Tension-Anxiety, 2) Vigour-Activity, 3) Depression-
Dejection, 4) Fatigue-Inertia, 5) Anger-Hostility, and 6) Confusion-Bewilderment. 
“Lively” (item 7) and “full of pep” (item 56) belong to the Vigor-Activity domain. 
The objectives of this study were to evaluate the difference in concept 
(if any) between these items and to translate them in 7 languages (Bulgarian, 
Estonian, French, German, Latvian, Portuguese and Slovakian). Methods: The 
POMS was translated following the Mapi methodology in compliance with the 
ISPOR guidelines. The process consisted of: 1) definition of each concept behind 
each item, 2) two forward translations by native translators, reconciliation of the 
translations, 3) one back-translation by an English-speaker fluent in the target lan-
guage, 4) final reconciliation, and 5) cognitive interviews with 35 native-speaking 
healthy subjects (n= 5 per country). Results: The first step of the translation 
process, i.e., definition of concepts, helped to clarify the conceptual differences 
between “lively” and “full of pep”. “Lively” had to be considered more as an action 
or behavior-based descriptor and “full of pep” as descriptive of the internal state. 
“Lively” was considered as the manifestation of feeling “full of pep”: With this 
definition in mind, each local team could find appropriate equivalents in each 
language. “Lively” was translated with literal wording in all languages. As for “full 
of pep”, translations varied from “enthusiastic” (Bulgarian, Portuguese) to “full of 
vitality” (Estonian, Slovakian) or “peppy” (German), “full of spirit” in French and 
“full of energy “in Latvian. The translations were well understood. ConClusions: 
“Lively” and “full of pep” are two different concepts which could be easily trans-
lated with the help of the developers who provided clear definitions of the intent 
of each item.
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objeCtives: The collection of patient-reported outcome (PRO) data is becoming 
more routine in oncology clinical trials and in clinical practice. The European 
Organisation for Research and Treatment of Cancer (EORTC) has developed and 
validated a number of PRO instruments, including the QLQ-BR23, a breast cancer 
specific measure. The objective of this study was to evaluate the internal reli-
ability of the EORTC QLQ-BR23 through reliability generalisation, a meta-analytic 
technique for pooling Cronbach’s alpha coefficients. Methods: A systematic lit-
erature review was undertaken of articles reporting the internal reliability of the 
EORTC QLQ-BR23 to identify potential studies for inclusion. Internal reliability was 
assessed for each of the five domains of the EORTC QLQ-BR23: Body (BI), Sexual 
Functioning (SF), Arm Symptoms (AS), Breast Symptoms (BS) and Systemic Therapy 
Side Effects (ST). Reliability generalisation was undertaken using fixed and random 
effects models for each domain. A value for Cronbach’s alpha coefficient above 
0.70 was considered to indicate reliability. Results: A total of 15 studies were 
found resulting in 18 datasets. Of the 3102 patients who had been recruited into 
studies 2888 had completed the BR-23 (93%). Almost half the studies had used 
European language versions of the instrument (7/15,47%). The unweighted average 
(fixed effects) Cronbach’s alpha coefficient ranged from 0.69 (breast symptoms) to 
0.86 (sexual functioning). There was statistically significant heterogeneity present 
across the 5 domains under the fixed effects model justifying the use of random 
effects. All Cronbach’s alpha > 0.7 under the random effects model, e.g. BI: 0.84 
(95%CI: 0.80-0.87), SF: 0.87 (95%CI: 0.84-0.89), AS: 0.71 (95%CI: 0.66-0.76), BS: 0.70 
(95%CI: 0.65-0.74) and ST: 0.71 (95%CI: 0.66-0.75). ConClusions: The results sug-
gest that the 5 domains of the EORTC QLQ-B23 are reliable and may be used in 
clinical trials and practice to capture PRO data to help inform trial, as well as 
individual clinical decision-making processes.
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objeCtives: Empirical data suggest that compliance with diabetes clinical prac-
tice recommendations is inadequate in primary care and that a large proportion of 
patients with diabetes remain at high risk. Changing physician practice patterns 
with use of electronic integrated system would provide a suite of technologies to 
support a full range of diabetes management activities. The objectives of this study 
are to determine the financial and clinical benefits of implementing information 
technology enabled diabetes management systems. Methods: The simulations 
were performed using the CORE model – widely validated and broadly used to 
enable a reliable estimation of costs and clinical effects associated with diabetes. 
Several estimates of care process improvements were derived, representing dif-
ferent percentage of patients covered by designed management activities and 
reaching target HbA1c. The primary outcome was medical cost savings and sec-
ondary measures include reduction of cardiovascular, cerebrovascular, neuropathy, 
nephropathy, and retinopathy clinical outcomes. Results: Gradual, sustained, 
and statistically significant improvements in a lifelong perspective performance 
measures were observed. According to simulation, as percentage of patients cov-
ered by information technology enabled diabetes management is growing, health 
care expenditures are reduced. With 10% of patients covered 6% of total patient 
costs were saved in comparison to 23% of total patient costs saved with 100% 
of patients covered. ConClusions: Implementation of information technology 
enabled diabetes management has demonstrated significant potential for improv-
ing processes of care, preventing the development of diabetic complications, and 
generating cost savings. Moreover, this improves the synthesis of information, 
the delivery of knowledge, and the efficiency of communication, allowing for 
coordination of care across delivery teams.
during 2012. As Italian EQ-5D-3L tariffs were not available at the time of the research, 
UK ones were used according to other comparable studies. Results concerning the 
first out of the 4 visits planned in SOLE study were reported as mean, standard 
deviation (SD), median and range. Correlation between EQ-5D-3L questionnaire and 
VAS scores was investigated via Kendall’s tau-b (Ktau-b). Results: 531 patients 
(mean age: 41.3; SD: 13.8; median: 41; range: 18—84) responded to EQ-5D-3L ques-
tionnaire (98.3%) and 536 to VAS (99.6%). The most frequently marked levels for 
EQ-5D-3L questionnaire were: 1 for mobility (66.2%) and self-care (85.2%); 2 for 
usual activities (51.8%), pain/discomfort (70.7%), and anxiety/depression (53.4%). 
Overall scores for EQ-5D-3L questionnaire and VAS were 0.7 (SD: 0.3; median: 0.8; 
range: -0.2—1) and 54.3 (SD: 20.8; median: 55; range: 0—100), respectively. Six out of 
531 EQ-5D-3L questionnaire responders (1.1%) valued their health state potentially 
worse than death (utility< 0). VAS scores of 10 or multiple of 10 were marked by 298 
out of 536 patients (55.6%). Ktau-b between EQ-5D-3L questionnaire and VAS scores 
reached 0.45 (p< 0.001). No significant differences were detected when EQ-5D-3L 
questionnaire and VAS scores were stratified according to hospital institutional 
features. ConClusions: Italian patients with moderate and severe CD report a 
remarkable reduction in HRQoL.
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objeCtives: Sample size (N) affects the robustness of psychometric results, but for 
evaluations of patient-reported outcome (PRO) measures, N is often a compromise 
between timelines and resources. Currently, there are no psychometric N guide-
lines or requirements for the development of PROs for use in clinical trials. The 
objective of this study is to review current N practices by conducting a systematic 
literature review of the psychometric methods and N choices made in the evaluation 
of PRO measures (for use in clinical trials) over the past 10 years. Methods: This 
systematic literature review included abstracts that described the psychometric 
evaluation of PRO measures that were likely developed for use in clinical trials. The 
review included English-language journal abstracts published in the past 10 years 
and identified in PubMed. Characteristics of each study were tabulated including 
the number of items and dimensions in each PRO of interest, the psychometric 
methods employed (e.g., internal consistency, test-retest reliability, factor analy-
sis, responsiveness), and N. Results: The literature search yielded 252 abstracts 
describing studies conducted mostly in Europe, Canada, and the United States. 
Preliminary results indicate that Ns ranged from approximately 40 to 4,000. The 
most frequently reported psychometric method was Cronbach’s alpha to quantify 
internal consistency. Approximately thirty percent of studies employed methods 
that demand the largest Ns such as item response theory (IRT) and factor analysis 
(FA). Ns for studies using IRT or FA analysis ranged from approximately 100 to 4,000 
participants. ConClusions: A wide range of Ns were employed for the psychomet-
ric evaluation of PROs developed for use in clinical trials. Ideally, researchers should 
consider the complexity of the PRO measure, its intended use, and the purpose of 
the evaluation when deciding on a study N. Additional studies should work toward 
developing best practices for PRO N guidelines in clinical trials.
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objeCtives: The EuroQol group observed problems related to the quality of valu-
ation data collected using the 5L protocol. The objective of this study was to test if 
reintroducing a ranking task prior to TTO could help to improve the quality of the 
data. Methods: Respondents were assigned to three different study branches in 
Spain, while just two branches were used in Japan. The control group (Arm 1, both 
countries) was the 5L protocol. The second branch (Arm 2, just Spain) was the EQ-VT 
preceded by a ranking task, in which the respondents were asked to rank the target 
health states using physical cards. The last branch (Arm 3, both countries) was 
with ranking prior to the EQ-VT, but unlike the second branch, the ranked states 
remained visible through the Composite TTO (C-TTO) tasks, and the C-TTO states 
order were determined by the rank order. A sample of respondents was randomly 
selected from Canary Islands and Tokyo population. All interviews were performed 
face to face. We compared the number of C-TTO-based inconsistencies. Results: 
The final sample size was 932 respondents (141 and 191 for branches 1 and 3 respec-
tively in Japan and 196,205 and 199 for branches 1, 2 and 3 respectively in Spain). 
The percentages of inconsistencies on C-TTO responses (state 55555 not valued as 
the worst state) were 13.27%, 10.73% and 13.57% for branches 1, 2, 3 respectively in 
Spain, and 20.6% and 10.5% for branches 1 and 3 in Japan. Grouping the data, the 
inconsistencies were 16.3%; 10.7% and 12.1%. However, none of the observed dif-
ferences were statistically significant. ConClusions: Differences in proportions 
observed in the Spanish data are smaller than in Japanese data. Given that Japanese 
team did all control arm interviews prior to ranking task interviews could play in 
favor of ranking arm (learning effects).
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objeCtives: Feeling “lively” or “full of pep” are common items used in PRO meas-
ures. The Profile of Mood States (POMS) identifies and assesses six fluctuating 
